A case of chronic plaque psoriasis in a woman with advanced breast cancer is reported. Treatment of the breast cancer with tamoxifen cleared the psoriatic skin lesions for several months, even after suspension of the hormonal treatment.
GreavesM.W.WeinteinG.D.: Treatment of psoriasis. N. Engl. J. Med., 332: 581–588, 1995.
2.
HughesB.R.CotterilJ.A.: The relationship of psoriasis to malignancy: a clinical report. Clin. Exp. Dermatol., 18:4144, 1993.
3.
KrausH.A.: Pharmaceutical composition: the invention concerns a new therapeutic preparation for use in the treatment of psoriasis. It contains, as active ingredient, tamoxifen. Patent no.P3705 8940 (Bonn, German Patent Office), 1987.
4.
MacNeilS.DawsonR.A.CrockerG.TuckerW.F.G. Bit- tiner B., SingletonJ.G., Hunter T, TierneyD.F.: Antiproliferative effects on keratinocytes of a range of clinically used drugs with calmodulin antagonist activity. Br. J. Dermatol., 128: 143–150, 1993.
5.
SmithO.P.HoffbrandA.V.BuckleyC.: Fludarabine and psoriasis. N. Engl. J. Med., 330: 1540–1541, 1994.
6.
ZinzaniP.L.RicciP.BernardiM., TuraS.: 2-chlorodeoxya- denosine in psoriasis treatment. Ann. Oncol., 6: 510, 1995.
